Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predicting neuropsychological abnormalities in multiple sclerosis.

Ralph H B Benedict1, Robert Zivadinov

  • 1Department of Neurology, School of Medicine, State University of New York, SUNY at Buffalo, Buffalo General Hospital, Neurology, Suite D-6, 100 High Street, 14203, USA. benedict@buffalo.edu

Journal of the Neurological Sciences
|April 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Patients With Relapsing Multiple Sclerosis Switching to Ocrelizumab Due to Suboptimal Treatment Response: Results of the 4-Year CASTING-LIBERTO Trial.

European journal of neurology·2026
Same author

Binary partitioning of human brain organization due to divergent human cytoskeletal evolution.

bioRxiv : the preprint server for biology·2026
Same author

Ultra-low-field MRI for bedside imaging of severe multiple sclerosis.

Journal of neurology·2026
Same author

The non-linear relationship between self-reported cognitive concerns and performance-based cognitive dysfunction in people with multiple sclerosis: a cross-sectional study.

Journal of neurology·2026
Same author

Feasibility of a 12-month, remotely delivered and supported aerobic walking exercise training program for brain and cognition in adults with multiple sclerosis.

Journal of neurology·2026
Same author

Cognition beyond relapses: cognitive progression independent of relapse activity reflects early smoldering neurodegeneration in multiple sclerosis.

Multiple sclerosis and related disorders·2026
Same journal

Distinguishing drug-target effects from natural lipid variation and incorporating imaging outcomes in Mendelian randomisation studies of multiple sclerosis.

Journal of the neurological sciences·2026
Same journal

Long-term social cognitive impairment after ischemic stroke: Frequency and association with lesion volume and location in an exploratory pilot study.

Journal of the neurological sciences·2026
Same journal

Subjective cognitive decline among U.S. Cancer survivors, 2017-2024: Prevalence, cancer-specific patterns, and associated factors.

Journal of the neurological sciences·2026
Same journal

Comment on "Comparative impact of mental and cardiovascular comorbidities on adverse outcomes in people with MS".

Journal of the neurological sciences·2026
Same journal

Comment on "Efficacy and safety of conventional immunosuppressant therapies in elderly patients with Neuromyelitis optica spectrum disorder: A target trial emulation study".

Journal of the neurological sciences·2026
Same journal

Increasing incidence of varicella-zoster virus meningitis in Japan, 2011-2022.

Journal of the neurological sciences·2026
See all related articles

The Multiple Sclerosis Neuropsychological Screening Questionnaire (MSNQ) effectively identifies cognitive issues in Multiple Sclerosis (MS) patients. It shows strong correlations with patient/informant reports and predicts future impairment, aiding in early detection of MS neurological complications.

Area of Science:

  • Neuroscience
  • Clinical Psychology
  • Radiology

Background:

  • Multiple Sclerosis (MS) is characterized by MRI-detectable changes and neuropsychological (NP) deficits.
  • Early identification of neurological complications in MS is crucial for patient management.
  • Screening tools are essential for detecting at-risk individuals.

Purpose of the Study:

  • To evaluate the reliability and predictive validity of the Multiple Sclerosis Neuropsychological Screening Questionnaire (MSNQ).
  • To assess the correlation between MSNQ reports and objective NP impairment in MS patients.
  • To determine if MSNQ can predict future NP decline and its relationship with disease markers.

Main Methods:

  • Data collected from 162 MS research participants and clinic attendees.

Related Experiment Videos

  • Analysis of correlations between patient- and informant-report MSNQ scores and NP impairment.
  • Longitudinal assessment of MSNQ's predictive power for NP testing at 51 weeks.
  • Correlation analysis with MRI measures (lesion burden, atrophy) and clinical data (disease course, disability).

    • Main Results:

    • Significant correlations were found between both patient and informant MSNQ reports and NP impairment.
    • Informant-report MSNQ showed stronger correlations with NP impairment than patient-report.
    • MSNQ demonstrated predictive validity for follow-up NP testing.
    • MSNQ correlated with MRI findings, disease progression (secondary progressive course), and vocational disability.

    Conclusions:

    • The MSNQ is a reliable and valid tool for screening neuropsychological and neuropsychiatric complications in MS.
    • Informant reports enhance the accuracy of the MSNQ in detecting NP dysfunction.
    • The MSNQ aids in identifying MS patients at risk for cognitive decline and disability.